Fintech PR
Jensen Partners Named Best Recruitment Company for Investor Relations & Asset Raising in U.S. By Private Equity Wire for Fifth Straight Year and Best Recruitment Company for Credit Firms in Europe for Second Consecutive Year
Jensen Partners Once Again Voted by GPs and LPs as the Leading Capital Formation Focused Executive Search Firm at 2023 Private Equity Wire U.S. Awards; Leading Recruitment Firm at 2023 Hedgeweek and Private Equity Wire European Credit Awards
NEW YORK, Oct. 30, 2023 /PRNewswire/ — Jensen Partners (“the Firm”), a leading global distribution focused executive search and corporate advisory firm, today announced it has been named “Best Recruitment Company for Investor Relations and Asset Raising” at Private Equity Wire’s 2023 U.S. Awards and “Best Executive Search Firm” at Hedgeweek and Private Equity Wire’s 2023 European Credit Awards. Nominated firms in the service provider categories for each award were based on a widespread survey of hundreds of credit fund managers and other key industry participants from across the alternative asset management space. This marks the fifth consecutive win for Jensen Partners from Private Equity Wire’s U.S. Awards, the second consecutive win from Hedgeweek and Private Equity Wire’s European Credit Awards, and the 11th time since 2017 that the Firm has been acknowledged by Private Equity Wire overall for its best-in-class integrated recruitment offerings.
“We are extremely grateful to the GPs and LPs that voted for us and appreciate the recognition and support for how we try and differentiate through data driven solutions. It’s been rewarding to witness the impact of the Firm’s unique approach to identifying and placing the most impactful capital formation candidates, especially during this incredibly complex and competitive fundraising environment,” said Sasha Jensen, Founder and CEO of Jensen Partners and Jensen DiversityMetrics™. “As demand for credit-focused investment opportunities has exploded, Jensen Partners has also served as a trusted partner to leaders throughout the asset class. We look forward to continuing to help them flourish in their pursuit of both talent and capital.”
This year’s award wins come as part of the publications’ annual set of awards, which each seek to recognize excellence among private fund managers and service providers throughout the U.S. and Europe and across a wide range of categories. This year, votes were cast by hundreds of GPs, LPs and service providers in the alternative investment space. In partnership with Bloomberg, both the 2023 Private Equity Wire U.S. Awards and the 2023 Hedgeweek and Private Equity Wire European Credit Awards were announced and celebrated at events in New York and London on Wednesday, October 25 and Thursday, October 26, respectively.
Jensen Partners specializes in recruiting and placing top capital raising and investment professionals for clients in the alternative investment industry. The cornerstone of Jensen Partners’ integrated suite of DEI and tech-enabled talent solutions is Jensen DiversityMetrics™, a database designed to help asset managers quantify, measure, report and improve workforce diversity, equity and inclusion. The platform features verified demographic data on more than 32,000 distribution professionals, including 11,000 who identify as coming from diverse backgrounds. The combined platform allows the Firm to generate a holistic picture of how each alternative investment firm stacks up against crucial diversity objectives, as well as provide access to long-term human capital data and, in turn, build relationships with clients based on trust and transparency.
About Jensen Partners
Jensen Partners is a global advisory, corporate development and executive search firm that leverages its extensive relationships in the investor and alternative asset management community to source and recruit leading capital raising and investment candidates. The Firm takes a data-driven approach, combining quantitative and qualitative insights to source and place the ideal human capital. In addition to executive search, Jensen Partners offers LP/GP referencing, proprietary 360° Investor Referencing™ methodology and compensation benchmarking and analysis. Known globally as a leader in the asset management space for its transformative talent and DEI solutions, Jensen Partners has been recognized by top industry and business publications: Jensen Partners been named one of the world’s most innovative companies with fewer than 100 employees by Fast Company; the “Best Recruiter” in Europe by Hedgeweek and Private Equity Wire; and the top DEI provider within Operations and Service by Fund Intelligence. To learn more, please visit www.jensen-partners.com.
About Jensen DiversityMetrics™
Jensen DiversityMetrics™ combines rich diversity analytics with the latest research from the field of human capital management, providing an objective, 360-degree view of where a firm stands on DEI and how they can make meaningful progress towards a more diverse, equitable and inclusive workforce. This includes verified demographic data for more than 32,000 investment and distribution professionals from across the industry, a candidate pipeline of over 11,000 investment and distribution professionals who self-identify as having a diverse background and a proprietary scoring algorithm that enables objective DEI comparisons across firms and industries. With Jensen DiversityMetrics™, firms can benchmark against competitors, develop diverse candidate pipelines, analyze hiring and retention practices, identify biases in workplace culture and report progress to investors.
Jensen Partners publishes JensenDiversityMetrics™ data and insights in its quarterly newsletter. To sign up for Jensen Partners’ newsletters, please visit: https://lp.constantcontactpages.com/su/tbmquk0.
Media Contacts
Prosek Partners
Max Berger
[email protected]
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News7 days ago
Al Hassan Ghazi Ibrahim Shaker Co. announces a strong start to FY24, reporting a 12.09% YoY increase in net profit to reach SAR 32.25 million in Q1-FY24
-
Latest News6 days ago
Newgen Recognized in the Gartner® Market Guide for Commercial Banking Cash Management and Trade Finance Solutions 2023 Report
-
Latest News6 days ago
Major Korean pension fund invests in carbon solutions with Stafford Capital Partners
-
Latest News6 days ago
Precisely Showcases Critical Role of Trusted Data in AI at the Gartner® Data & Analytics Summit in London
-
Latest News6 days ago
One United Properties posts a consolidated turnover of 84.3 million euros and a gross profit of 37 million euros in the first three months of 2024
-
Latest News5 days ago
KuCoin Research Report Reveals: $1 Billion in Financing and Rising Stablecoin Issuance Amid Market Fluctuations
-
Latest News3 days ago
B Lab UK research reveals UK public back change to company law to put people, the planet and profit on more equal footing
-
Latest News5 days ago
MENA Fintech Association Sets Sights on EU Expansion, in Partnership With Hungarian Fintechs